BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 7730480)

  • 1. Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: mutation of K-ras and overexpression of the p53 protein product.
    van Es JM; Polak MM; van den Berg FM; Ramsoekh TB; Craanen ME; Hruban RH; Offerhaus GJ
    J Clin Pathol; 1995 Mar; 48(3):218-22. PubMed ID: 7730480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region.
    Sturm PD; Hruban RH; Ramsoekh TB; Noorduyn LA; Tytgat GN; Gouma DJ; Offerhaus GJ
    J Pathol; 1998 Nov; 186(3):247-53. PubMed ID: 10211112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears.
    Apple SK; Hecht JR; Novak JM; Nieberg RK; Rosenthal DL; Grody WW
    Am J Clin Pathol; 1996 Mar; 105(3):321-6. PubMed ID: 8602613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
    Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours.
    Van Laethem JL; Vertongen P; Deviere J; Van Rampelbergh J; Rickaert F; Cremer M; Robberecht P
    Gut; 1995 May; 36(5):781-7. PubMed ID: 7797131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
    Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
    J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.
    Dergham ST; Dugan MC; Kucway R; Du W; Kamarauskiene DS; Vaitkevicius VK; Crissman JD; Sarkar FH
    Int J Pancreatol; 1997 Apr; 21(2):127-43. PubMed ID: 9209954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma.
    Rall CJ; Yan YX; Graeme-Cook F; Beauchamp R; Yandell DW; Povoski SP; Rustgi AK
    Pancreas; 1996 Jan; 12(1):10-7. PubMed ID: 8927612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer.
    Salek C; Benesova L; Zavoral M; Nosek V; Kasperova L; Ryska M; Strnad R; Traboulsi E; Minarik M
    World J Gastroenterol; 2007 Jul; 13(27):3714-20. PubMed ID: 17659731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
    Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
    Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma.
    Kondo H; Sugano K; Fukayama N; Kyogoku A; Nose H; Shimada K; Ohkura H; Ohtsu A; Yoshida S; Shimosato Y
    Cancer; 1994 Mar; 73(6):1589-94. PubMed ID: 8156485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-ras mutation in focal proliferative lesions of human pancreas.
    Terhune PG; Phifer DM; Tosteson TD; Longnecker DS
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):515-21. PubMed ID: 9641496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer.
    Boadas J; Mora J; Urgell E; Puig P; Roca M; Cussó X; Capellà G; Lluís F; Farré A
    Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1153-9. PubMed ID: 11711770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.
    DiGiuseppe JA; Hruban RH; Offerhaus GJ; Clement MJ; van den Berg FM; Cameron JL; van Mansfeld AD
    Am J Pathol; 1994 May; 144(5):889-95. PubMed ID: 8178941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
    Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
    J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status.
    Berger DH; Chang H; Wood M; Huang L; Heath CW; Lehman T; Ruggeri BA
    Cancer; 1999 Jan; 85(2):326-32. PubMed ID: 10023699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" technique.
    Behn M; Qun S; Pankow W; Havemann K; Schuermann M
    Clin Cancer Res; 1998 Feb; 4(2):361-71. PubMed ID: 9516924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diagnosis of exocrine pancreatic cancer using a percutaneous technique.
    Evans DB; Frazier ML; Charnsangavej C; Katz RL; Larry L; Abbruzzese JL
    Ann Surg Oncol; 1996 May; 3(3):241-6. PubMed ID: 8726178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses.
    Villanueva A; Reyes G; Cuatrecasas M; Martínez A; Erill N; Lerma E; Farré A; Lluís F; Capellá G
    Gastroenterology; 1996 May; 110(5):1587-94. PubMed ID: 8613066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.